Palatin Technologies (PTN) Metrics: History & Chart

Palatin Technologies, Inc.(PTN)

Biotechnology · Monmouth Junction, NJ

$9.64+0.15 (+1.64%)

Delayed quote: Oct 6, 2026, 12:56 PM EDT

About Palatin Technologies, Inc.

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.

Monmouth Junction, NJ

25 employees

palatin.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Carl Spana

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-1.04%
30D Total Return	-25.35%
YTD Total Return	-38.36%
1Y Total Return	+20.77%
3Y Total Return	-89.52%
5Y Total Return	-98.24%
10Y Total Return	-98.67%
15Y Total Return	-98.42%
20Y Total Return	-99.97%

2026	-38.36%
2025	-72.29%
2024	-72.11%
2023	+55.47%
2022	-79.92%
2021	-25.00%
2020

CAGR TTM	+20.66%
CAGR 3Y	-52.85%
CAGR 5Y	-55.41%
CAGR 10Y	-35.08%
CAGR 15Y	-24.16%
CAGR 20Y	-33.29%

PE Ratio	6.28
PE Ratio Avg TTM	6.11
PE Ratio Avg 3Y	6.11
Current VS TTM Avg	+2.83%
Current VS 3Y Avg	+2.83%
Current VS 5Y Avg	+2.83%

All Metrics

PTN Valuation Metrics

PTN Stock Price Metrics

PTN Dividend Metrics

PTN Growth Rate Metrics

PTN Discounted Cash Flow Metrics

PTN Returns By Period

PTN Yearly Returns

PTN Average Annual Returns By Period (CAGR)

PTN Revenue Metrics

PTN PE Ratio Metrics

PTN PS Ratio Metrics

PTN PB Ratio Metrics

PTN Price to Free Cash Flow Ratio Metrics

PTN Debt to Equity Ratio Metrics

PTN PEG Ratio Metrics

PTN FCF Yield

PTN Earnings Yield

PTN EBITDA Yield

PTN OCF Yield

PTN EV/EBIT Ratio Metrics

PTN EV/EBITDA Ratio Metrics

PTN EV/Assets Ratio Metrics

PTN EV/Sales Ratio Metrics

PTN Current Ratio Metrics

PTN Quick Ratio Metrics

PTN ROIC Metrics

PTN Return on Assets Metrics

PTN Return on Equity Metrics

PTN Net Profit Margin Metrics

PTN Gross Profit Margin Metrics

PTN Tax Rate Metrics

PS Ratio	2.82
PS Ratio Avg TTM	1.77
PS Ratio Avg 3Y	141.84
Current VS TTM Avg	+58.90%
Current VS 3Y Avg	-98.01%
Current VS 5Y Avg	-99.04%

PB Ratio	5.56
PB Ratio Avg TTM	15.14
PB Ratio Avg 3Y	256.25
Current VS TTM Avg	-63.29%
Current VS 3Y Avg	-97.83%
Current VS 5Y Avg	-94.32%

PFCF Ratio	116.95
PFCF Ratio Avg TTM	2103.03
PFCF Ratio Avg 3Y	2594.52
Current VS TTM Avg	-94.44%
Current VS 3Y Avg	-95.49%
Current VS 5Y Avg	-95.49%

Debt/Equity Ratio	0.03
Debt/Equity Ratio Avg TTM	0.08
Debt/Equity Ratio Avg 3Y	(0.04)
Current VS TTM Avg	-57.20%
Current VS 3Y Avg	+182.50%
Current VS 5Y Avg	+441.82%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	0.86%
FCF Yield Avg TTM	0.04%
FCF Yield Avg 3Y	0.04%
Current VS TTM Avg	+1851.04%
Current VS 3Y Avg	+2114.98%
Current VS 5Y Avg	+2114.98%

Earnings Yield	15.92%
Earnings Yield Avg TTM	16.05%
Earnings Yield Avg 3Y	16.05%
Current VS TTM Avg	-0.79%
Current VS 3Y Avg	-0.79%
Current VS 5Y Avg	-0.79%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	154.55
Ev/Ebit Ratio Avg TTM	197.54
Ev/Ebit Ratio Avg 3Y	332.66
Current VS TTM Avg	-21.76%
Current VS 3Y Avg	-53.54%
Current VS 5Y Avg	-53.54%

Ev/Ebitda Ratio	154.26
Ev/Ebitda Ratio Avg TTM	197.20
Ev/Ebitda Ratio Avg 3Y	334.09
Current VS TTM Avg	-21.77%
Current VS 3Y Avg	-53.83%
Current VS 5Y Avg	-53.83%

Ev/Assets Ratio	3.51
Ev/Assets Ratio Avg TTM	0.98
Ev/Assets Ratio Avg 3Y	60.34
Current VS TTM Avg	+258.25%
Current VS 3Y Avg	-94.18%
Current VS 5Y Avg	-94.37%

Ev/Sales Ratio	2.27
Ev/Sales Ratio Avg TTM	1.08
Ev/Sales Ratio Avg 3Y	144.61
Current VS TTM Avg	+110.74%
Current VS 3Y Avg	-98.43%
Current VS 5Y Avg	-99.25%

Current Ratio	4.61
Current Ratio Avg TTM	2.76
Current Ratio Avg 3Y	0.75
Current VS TTM Avg	+67.06%
Current VS 3Y Avg	+517.55%
Current VS 5Y Avg	+102.28%

Quick Ratio	4.61
Quick Ratio Avg TTM	2.76
Quick Ratio Avg 3Y	0.73
Current VS TTM Avg	+67.06%
Current VS 3Y Avg	+530.41%
Current VS 5Y Avg	+105.59%

ROIC	(125.44%)
ROIC Avg 3Y	(952.82%)
ROIC Avg 5Y	(367.93%)
Current VS 3Y Avg	+86.83%
Current VS 5Y Avg	+65.91%
Current VS 10Y Avg	-88.81%

ROA	(98.29%)
ROA Avg TTM	(23.29%)
ROA Avg 3Y	(53.71%)
Current VS TTM Avg	-322.05%
Current VS 3Y Avg	-83.01%
Current VS 5Y Avg	-154.88%

ROE	(125.30%)
ROE Avg TTM	(89.42%)
ROE Avg 3Y	(89.42%)
Current VS TTM Avg	-40.12%
Current VS 3Y Avg	-40.12%
Current VS 5Y Avg	+21.68%

Net Profit Margin	(63.54%)
Net Profit Margin Avg TTM	(1538.57%)
Net Profit Margin Avg 3Y	(117.38%)
Current VS TTM Avg	+95.87%
Current VS 3Y Avg	+45.87%
Current VS 5Y Avg	+93.56%

Gross Profit Margin	99.63%
Gross Pft Margin Avg TTM	76.31%
Gross Pft Margin Avg 3Y	53.52%
Current VS TTM Avg	+30.57%
Current VS 3Y Avg	+86.17%
Current VS 5Y Avg	+61.97%

Tax Rate	0.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	+100.00%